Market Cap 52.20M
Revenue (ttm) 0.00
Net Income (ttm) -38.51M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 6.18
Volume 208,500
Avg Vol 114,042
Day's Range N/A - N/A
Shares Out 6.45M
Stochastic %K 82%
Beta -1.88
Analysts Strong Sell
Price Target $13.00

Company Profile

KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases. The company's lead product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; and limbal stem cell deficiency and other rare corneal diseases. Its preclinical development product consists of KPI-014 for the treatment of rare inherited retinal diseases. The comp...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 996 5252
Fax: 781 642 0399
Address:
1167 Massachusetts Avenue, Arlington, United States
Drive2
Drive2 Jul. 28 at 11:10 PM
$KALA Investors are asleep on this one. They didn't watch the KOL presentation.
0 · Reply
JazsminC
JazsminC Jul. 28 at 2:51 PM
$KALA Consolidation and some people taking profits if they have been holding since april.
0 · Reply
MythicalDragon
MythicalDragon Jul. 28 at 2:26 PM
$KALA Looks good for a nice uptrend from here
0 · Reply
Drive2
Drive2 Jul. 27 at 4:58 PM
$KALA $3B sales estimates once this is approved.
0 · Reply
JoseRodriguez1994
JoseRodriguez1994 Jul. 27 at 4:44 PM
$KALA Interesting
0 · Reply
Drive2
Drive2 Jul. 27 at 12:58 PM
$KALA Investors completely asleep on this one. Watch the KOL presentation especially the Q and A.
0 · Reply
yuezhoulin123
yuezhoulin123 Jul. 26 at 3:15 AM
$KALA wow
0 · Reply
Ray_Khan
Ray_Khan Jul. 26 at 3:05 AM
Week of 7/28/25 List: *Down to 1/4 position $LIDR . I wanna see where this goes. *Holding my remaining 1/4 position in $KALA as well. $7 stop. *Full position $OLB . I generally agree with the bullish DD and I'd be surprised if we don't see at least a 200% move when approval drops. And that's about to happen, in fact, it may already have and they're timing the release for optimal effect. I would. *Not sure what to make of my $TSLA here. I'm still a confirmed Tesla bull long term, but I'm going to pause my weekly adds temporarily and see what happens. I also like bagels with Lox and cream cheese baby. LFG!
1 · Reply
Stmkr
Stmkr Jul. 26 at 2:25 AM
$KALA Base case scenario is KALA needing a ph3 for approval. But if results from current trial are convincing enough I wouldn't rule out an early approval pathway
1 · Reply
Stmkr
Stmkr Jul. 26 at 2:23 AM
$KALA Early phase data pretty impressive. Especially the patienr with PCED for 213 days that resolved within a week of KPI-012 treatment.
0 · Reply
Latest News on KALA
KALA BIO to Present at Jefferies Global Healthcare Conference

May 29, 2025, 8:00 AM EDT - 2 months ago

KALA BIO to Present at Jefferies Global Healthcare Conference


KALA BIO Announces Chief Executive Officer Transition

Feb 12, 2025, 8:00 AM EST - 5 months ago

KALA BIO Announces Chief Executive Officer Transition


KALA BIO Announces $10,750,000 Private Placement

Dec 30, 2024, 8:00 AM EST - 7 months ago

KALA BIO Announces $10,750,000 Private Placement


Kala Pharmaceuticals Announces Reverse Stock Split

Oct 20, 2022, 7:30 AM EDT - 3 years ago

Kala Pharmaceuticals Announces Reverse Stock Split


Why Kala Pharmaceuticals Shares Are Rising Today

May 23, 2022, 10:17 AM EDT - 3 years ago

Why Kala Pharmaceuticals Shares Are Rising Today


This Microcap Pharma Stock Almost Doubled Today - Read Why

Mar 8, 2022, 4:19 PM EST - 3 years ago

This Microcap Pharma Stock Almost Doubled Today - Read Why


Drive2
Drive2 Jul. 28 at 11:10 PM
$KALA Investors are asleep on this one. They didn't watch the KOL presentation.
0 · Reply
JazsminC
JazsminC Jul. 28 at 2:51 PM
$KALA Consolidation and some people taking profits if they have been holding since april.
0 · Reply
MythicalDragon
MythicalDragon Jul. 28 at 2:26 PM
$KALA Looks good for a nice uptrend from here
0 · Reply
Drive2
Drive2 Jul. 27 at 4:58 PM
$KALA $3B sales estimates once this is approved.
0 · Reply
JoseRodriguez1994
JoseRodriguez1994 Jul. 27 at 4:44 PM
$KALA Interesting
0 · Reply
Drive2
Drive2 Jul. 27 at 12:58 PM
$KALA Investors completely asleep on this one. Watch the KOL presentation especially the Q and A.
0 · Reply
yuezhoulin123
yuezhoulin123 Jul. 26 at 3:15 AM
$KALA wow
0 · Reply
Ray_Khan
Ray_Khan Jul. 26 at 3:05 AM
Week of 7/28/25 List: *Down to 1/4 position $LIDR . I wanna see where this goes. *Holding my remaining 1/4 position in $KALA as well. $7 stop. *Full position $OLB . I generally agree with the bullish DD and I'd be surprised if we don't see at least a 200% move when approval drops. And that's about to happen, in fact, it may already have and they're timing the release for optimal effect. I would. *Not sure what to make of my $TSLA here. I'm still a confirmed Tesla bull long term, but I'm going to pause my weekly adds temporarily and see what happens. I also like bagels with Lox and cream cheese baby. LFG!
1 · Reply
Stmkr
Stmkr Jul. 26 at 2:25 AM
$KALA Base case scenario is KALA needing a ph3 for approval. But if results from current trial are convincing enough I wouldn't rule out an early approval pathway
1 · Reply
Stmkr
Stmkr Jul. 26 at 2:23 AM
$KALA Early phase data pretty impressive. Especially the patienr with PCED for 213 days that resolved within a week of KPI-012 treatment.
0 · Reply
Stmkr
Stmkr Jul. 26 at 2:20 AM
$KALA "Oxervate reported US 2023 annual sales exceeded $828M*" Oxervate is approved for only 1/3 of PCED patients and is a complicated regimen (6 times daily + complicated preparation) with topical AEs being common (e.g. pain) KPI-012 aiming for a broad PCED label, QID dosing, is ready to use (no steps to prepare for administration) and is not only painless but on the contrary results in very quick resolution of the pain. Guess what happens to KALA price when positive results are announced late Q3 (current MC around 50M!). Check what happened to KALA when ph1b results were announced
1 · Reply
StockScanners
StockScanners Jul. 25 at 10:43 PM
$KALA needs to hold above 7.85
0 · Reply
Brachina
Brachina Jul. 25 at 8:45 PM
$KALA nice close. Have a nice weekend
0 · Reply
JazsminC
JazsminC Jul. 25 at 8:07 PM
$KALA Well that was a nice way to end the week
0 · Reply
cfvk
cfvk Jul. 25 at 7:37 PM
$KALA my 5.6 enjoying, just been flipping it from 5s to 6s but it's getting attention
0 · Reply
JazsminC
JazsminC Jul. 25 at 7:35 PM
$KALA Wow we are movin
0 · Reply
Raxothus
Raxothus Jul. 25 at 4:38 PM
EOD FOLLOW-UP – 07/25/25 Tracking continuation watch from 07/24 based on today’s highs vs prior close ✅ $KALA – Closed 7.10, weak open, hit 7.90 HOD (+11.3%), but never reclaimed VWAP. ✅ $OPTX – Closed 2.28, hit 2.50 HOD (+9.6%), reclaimed VWAP early, strong push. ✅ $ENGS – Closed 3.09, ran to 3.14 HOD (+1.6%), low-range but clean continuation with volume. ❌ $PHOE – Closed 10.73, hit 10.71 (–0.2%), no gap or VWAP reclaim. ❌ $CIO – Closed 6.90, no move, no volume. No trigger. Recap Total: 5 Winners: 3 Faders: 2 Accuracy: 60% ⚠️ $OPTX and $ENGS confirmed with volume. $KALA had range but failed VWAP hold. $PHOE and $CIO offered no valid setup. #VWAP #Continuation #SmallCaps #DayTrading #EODSetups #Accountability
0 · Reply
Nothin
Nothin Jul. 25 at 4:10 PM
$KALA Top Institutional Holders (As of March/December 2024 filings) 1. Baker Bros. Advisors L.P. • Owns approximately 1,201,894 shares (~19.7% of the company), following a 34.8% increase in their stake during Q4 2024 • Position valued at about $8.34 million  2. Cormorant Asset Management, LP • Holds 609,027 shares, representing 9.99% of outstanding shares • This is a new position reported as of Dec 31, 2024  3. SR One Capital Management, LP • Controls 598,940 shares after boosting their position by 35% during Q4 • Represents around 1% of their portfolio (approx. $4.16M stake)  4. Perceptive Advisors LLC • Holds 277,610 shares, valued at about $1.59M (as of March 31, 2025)  Also notable: AIGH Capital Management LLC • Made a new investment of 121,302 shares (~$842K) in Q4 2024 • Not yet at the same scale, but an emerging player
0 · Reply
_ICEMAN
_ICEMAN Jul. 25 at 4:00 PM
$KALA news coming?
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jul. 25 at 3:20 PM
$KALA $7.89 high thank you for the awesome overnight swing... 49 straight overnight swings without a loss the streak continues🏆🏆
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jul. 25 at 2:15 PM
$KALA $7.50 to break for more.... Still going strong 🚨 🚨
0 · Reply
JazsminC
JazsminC Jul. 25 at 2:10 PM
$KALA Volume is really good almost at average
0 · Reply